A $9 billion biotech deal

Originally aired: Friday, January 26, 2018
Category: News
One of the most prominent immunotherapy companies, Juno Therapeutics, announced a deal to be acquired by Celgene. Plus, we dive into the tech renaissance in Pittsburgh and complain about Seattle's bike lanes. Read all our coverage at GeekWire.com.

You might also like...